Literature DB >> 8041128

Intragraft expression of messenger RNA for interleukin-6 and tumor necrosis factor-alpha is a predictor of rat small intestine transplant rejection.

D G Farmer1, S V McDiarmid, J Kuniyoshi, M E Robert, A Shaked, R W Busuttil.   

Abstract

Detection of rejection after small intestine transplantation (SIT) is difficult, relying largely on histopathology. The purpose of this study was to determine if the intragraft expression of messenger RNA (mRNA) for interleukin-2 receptor (IL-2R), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF) correlated with rejection in a unidirectional, heterotopic rat SIT model. Graft samples were obtained on postoperative day (POD) 3, 5, 7, 8, 9, 10, 12, and 14. After staining, formalin-fixed samples were blindly evaluated for rejection. Reverse transcriptase polymerase chain reaction (rtPCR) using primers specific for beta-actin, IL-2R, IL-6, and TNF was performed on liquid nitrogen-frozen samples. Semiquantitation was accomplished using radionuclide incorporation and beta-scintillation counting. Intestinal histopathology in all isografts (ISO) and POD 3 allografts (ALLO) was normal. Rejection progressed in ALLO from mild on POD 5 to severe by POD 8. rtPCR analysis revealed constitutive expression of IL-2R mRNA in both ISO and ALLO. TNF and IL-6 demonstrated significant increases in mRNA expression in ALLO compared to ISO beginning on POD 5. In summary, intragraft expression of IL-2R mRNA demonstrated late up-regulation in ALLO which did not correlate with rejection. TNF and IL-6 mRNA expression predicted rat SIT rejection. rtPCR analysis of TNF and IL-6 may serve as a useful diagnostic adjunct for rat SIT rejection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041128     DOI: 10.1006/jsre.1994.1121

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Low-level laser therapy attenuates the myeloperoxidase activity and inflammatory mediator generation in lung inflammation induced by gut ischemia and reperfusion: a dose-response study.

Authors:  Flávia Mafra de Lima; Flávio Aimbire; Humberto Miranda; Rodolfo de Paula Vieira; Ana Paula Ligeiro de Oliveira; Regiane Albertini
Journal:  J Lasers Med Sci       Date:  2014

2.  Proteomic analysis reveals innate immune activity in intestinal transplant dysfunction.

Authors:  Anjuli R Kumar; Xiaoxiao Li; James F Leblanc; Douglas G Farmer; David Elashoff; Jonathan Braun; David Ziring
Journal:  Transplantation       Date:  2011-07-15       Impact factor: 4.939

Review 3.  Innovations in Immunosuppression for Intestinal Transplantation.

Authors:  Harween Dogra; Jonathan Hind
Journal:  Front Nutr       Date:  2022-06-15

4.  Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.

Authors:  Yang Yang; Hong-Li Song; Wen Zhang; Ben-Juan Wu; Nan-Nan Fu; Wei-Ping Zheng; Chong Dong; Chong Don; Zhong-Yang Shen
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

5.  Interleukin‑6 RNA knockdown ameliorates acute lung injury induced by intestinal ischemia reperfusion in rats by upregulating interleukin‑10 expression.

Authors:  Bing Yuan; Liu-Lin Xiong; Mu-Dong Wen; Piao Zhang; Hong-Yu Ma; Ting-Hua Wang; Yun-Hui Zhang
Journal:  Mol Med Rep       Date:  2017-07-06       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.